Enveric Biosciences is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of neuropsychiatric disorders. The company leverages its discovery and development platform, The Psybrary™, to create a portfolio of New Chemical Entities for specific mental health indications.

Enveric Biosciences, Inc.

Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.

COM:ENVERIC

Enveric Biosciences

Last Close

1.59

14/02 21:00

Market Cap

3.72M

Beta: -

Volume Today

494.28K

Avg: -

name

homepage url

country

employee count

sector

industry

Description

competitor of

Metrics